Norlake laboratory refrigerators and environmental chambers provide safe, secure, effortless storage for valuable laboratory products. From routine scientific storage to the critical demands of pharmaceutical laboratories and blood banks, Norlake has units for the whole range of scientific storage needs.

SAN DIEGO, June 18 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced that the company has developed a proprietary vaccine adjuvant, Poly IC-Poly Arginine (Poly-ICR), that has broad potential for use in both therapeutic and prophylactic vaccines.

TORONTO, June 18 /PRNewswire/ -- The Concerned Shareholders of Biovail Corporation (NYSE: BVF)(TSX: BVF) said today that they welcomed a report by Glass Lewis & Co., which sharply criticized the incumbent board and recommended 'Do Not Vote' for any of the company's nominees.

SAN DIEGO, June 18 /PRNewswire-FirstCall/ -- Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), announced today at the 2008 BIO International Convention that it has exercised its option to obtain a commercial license to zinc finger technology from Richmond, Calif.-based Sangamo BioSciences (Nasdaq: SGMO). The license allows Dow AgroSciences to commercialize products incorporating or developed from plant cells using Sangamo's zinc finger DNA-binding protein (ZFP(TM)) technology, in agricultural crops, industrial products and plant-derived biopharmaceuticals. Sangamo and Dow AgroSciences have been collaborating in research to apply ZFP technology to plants under a three-year research and commercial license option agreement initiated in October 2005. Dow AgroSciences exercised its commercial option four months before expiration of the option period.

SCOTTSDALE, Ariz., June 17 /PRNewswire/ -- MedPredict has published a new report designed to provide critical strategic insight for pharma and biotech companies with a stake in the market for diagnostics and treatments in this disease area. The report, entitled "Thought Leader Insight & Analysis: Alzheimer's Disease," is based on in-depth interviews conducted with a panel of physician thought leaders actively involved in ongoing research.

MARIETTA, Ga., June 17 /PRNewswire/ -- Solvay Pharmaceuticals, Inc. announced today that a new analysis of pivotal study data conducted by the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center showed that initial treatment response of hypogonadal men with AndroGel(R) (testosterone gel) 1% CIII had similar effects on subjects, regardless of weight and body mass index (BMI). These study results were presented today at the 2008 Endocrine Society Annual Meeting (ENDO) in San Francisco.

NEW YORK, June 17 /PRNewswire/ -- Mergent, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange Traded Funds, today announced the quarterly rebalancing of the Indexes. The following securities will be added and deleted in the Indexes effective before the opening of trading on NYSE Arca on June 23, 2008.

LIBERTYVILLE, Ill., and BOSTON, June 17 /PRNewswire/-- Families of Spinal Muscular Atrophy (FSMA) and Paratek Pharmaceuticals, Inc. today announced they have extended and significantly expanded their joint research and development collaboration to develop a drug candidate for the treatment of Spinal Muscular Atrophy (SMA), the leading genetically inherited cause of death of children under the age of two years. The collaboration is focused on optimizing and advancing into the clinic a novel small molecule within Paratek's library derived from the tetracycline class of compounds.

REDWOOD CITY, Calif., June 17 /PRNewswire/ -- Ingenuity Systems, the leading provider of information solutions for life science researchers, today released IPA 6.3, the newest version of its pathway analysis and life sciences knowledge software. IPA now supports Affymetrix GeneChip(R) Exon Arrays and several new animal and plant species.

By Pierre Bertrand University of Mississippi researchers have found that tetrahydrocannabinol, or THC, the active chemical in marijuana, has reached record levels in the United States.